BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29575326)

  • 1. The CRISPR/Cas revolution reaches the RNA world: Cas13, a new Swiss Army knife for plant biologists.
    Wolter F; Puchta H
    Plant J; 2018 Jun; 94(5):767-775. PubMed ID: 29575326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming plant biology and breeding with CRISPR/Cas9, Cas12 and Cas13.
    Schindele P; Wolter F; Puchta H
    FEBS Lett; 2018 Jun; 592(12):1954-1967. PubMed ID: 29710373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation.
    Mahas A; Neal Stewart C; Mahfouz MM
    Biotechnol Adv; 2018; 36(1):295-310. PubMed ID: 29197619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR/Cas revolution continues: From efficient gene editing for crop breeding to plant synthetic biology.
    Kumlehn J; Pietralla J; Hensel G; Pacher M; Puchta H
    J Integr Plant Biol; 2018 Dec; 60(12):1127-1153. PubMed ID: 30387552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas13 as a Tool for RNA Interference.
    Ali Z; Mahas A; Mahfouz M
    Trends Plant Sci; 2018 May; 23(5):374-378. PubMed ID: 29605099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications.
    Rautela I; Uniyal P; Thapliyal P; Chauhan N; Bhushan Sinha V; Dev Sharma M
    Gene; 2021 Jun; 785():145615. PubMed ID: 33775851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and prospects in plant genome editing.
    Yin K; Gao C; Qiu JL
    Nat Plants; 2017 Jul; 3():17107. PubMed ID: 28758991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering virus resistance via CRISPR-Cas systems.
    Mahas A; Mahfouz M
    Curr Opin Virol; 2018 Oct; 32():1-8. PubMed ID: 30005359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editing plants for virus resistance using CRISPR-Cas.
    Green JC; Hu JS
    Acta Virol; 2017; 61(2):138-142. PubMed ID: 28523919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing by natural and engineered CRISPR-associated nucleases.
    Wu WY; Lebbink JHG; Kanaar R; Geijsen N; van der Oost J
    Nat Chem Biol; 2018 Jul; 14(7):642-651. PubMed ID: 29915237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cpf1 CRISPR-Cas protein expands genome-editing tools.
    Fagerlund RD; Staals RH; Fineran PC
    Genome Biol; 2015 Nov; 16():251. PubMed ID: 26578176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects.
    Li Y; Peng N
    Front Microbiol; 2019; 10():2471. PubMed ID: 31708910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances of using CRISPR-Cas13a system for tumor diagnosis and treatment].
    Zhang J; Luo J; Zhao Y; Huang Y; Chen J; Hao W
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2079-2086. PubMed ID: 35786463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.